Cerebras Systems reported revenue of $510 million for the year to Dec. 31 and filed for a U.S. Initial public offering on April 17. The Sunnyvale, California, chipmaker swung back to profitability after a loss the previous year. The company plans to list on Nasdaq under the ticker CBRS, with Morgan Stanley, Citigroup, Barclays and UBS as lead underwriters. This filing comes as bankers and issuers see a renewed pickup in AI-linked listings.
Cerebras unveiled a fresh registration with U.S. Regulators on April 17. The firm had previously filed in 2024 and then withdrew its offering after a late-2024 funding round that valued the company at about $8 billion. The new filing restarts that push to go public.
Revenue rose in the year to Dec. 31 from the prior year, and the company swung back to profitability after a loss the year before. This figures point to a rapid revenue lift and a swing back to profitability in the latest reporting period.
The technology and the customers
Cerebras makes large-scale chips designed to speed training and inference for big AI models. The company sells wafer-scale engine chips. Those are engineered to avoid dependence on high-bandwidth memory, which many in the industry call a bottleneck.
Management has aimed growth at inference workloads, the part of AI that answers user queries. Cerebras has also tied much of its expansion to a multiyear deployment by OpenAI.
The company disclosed a $20 billion multi-year deal that includes a multiyear deployment of Cerebras chips by the ChatGPT creator.
That commercial link matters. Big customers change the revenue profile for a hardware supplier. And a multiyear commitment from a prominent AI developer gives the offering a concrete growth story to present to investors.
Why the timing matters to markets
Underwriters on the deal include Morgan Stanley, Citigroup, Barclays and UBS. The banks typically weigh market appetite before setting a timetable and pricing range. Cerebras' filing signals confidence among issuers and bankers that investor demand for AI-related listings has strengthened since a slowdown in March.
Analysts have been watching whether artificial intelligence-linked companies will lead a revival of tech listings. The filing fits that pattern. It also follows clearance the company said it obtained from a U.S. Foreign investment review after scrutiny over a previous investor and customer relationship.
The market backdrop
The filing arrives after a brief lull in new offerings in March. Volatility tied to geopolitical tensions and a selloff in tech stocks had curbed appetite. In recent weeks, though, issuers have returned to the market as sentiment stabilizes.
Investors are watching which AI hardware plays can scale into broader enterprise adoption. Cerebras is pitching a different technical approach to the same problem many chipmakers face. The company sees the market for inference as a growth path distinct from the training-focused products of other firms.
For public-market investors, the questions will be about margin durability, customer concentration and how fast revenue can expand beyond anchor deals. Cerebras' latest annual revenue and the OpenAI agreement give underwriters concrete figures to present in marketing documents to potential institutional buyers.
Related Articles
- 137 Ventures Raises $700M as SpaceX IPO Nears
- S&P Futures Slip 0.1% as Brent Tops $110 on Mideast Tensions
- Sauna raves fuel a new nightlife revenue stream
Cerebras aims to list on Nasdaq under the symbol CBRS, with Morgan Stanley, Citigroup, Barclays and UBS as lead underwriters.
This article was created with AI assistance.
